卡瑞利珠单抗导致反应性毛细血管增生症  

Camrelizumab leading to reactive cutaneousscapillaryendothelial hyperplasia:a case report

作　　者：黄月香 李兴 肖敏[1] 马文宇[2] HUANG Yuexiang;LI Xing;XIAO Min;MA Wenyu(Departmen of Dermatology,Liuzhou City People's Hospital,Liuzhou 545000,China;Department of Medical Cosmetic,The Affiliated Hospital of Qinghai University,Xining 810000,China)

机构地区：[1]柳州市人民医院皮肤科,广西柳州545000 [2]青海大学附属医院医疗美容科,青海西宁810000

出　　处：《临床皮肤科杂志》2023年第9期551-552,共2页Journal of Clinical Dermatology

摘　　要：报告1例卡瑞利珠单抗导致反应性毛细血管增生症。患者男,69岁。全身出现多发鲜红色丘疹4个月余。皮肤科检查:右侧颧部一1.5 cm×2 cm带蒂暗红色肿物,无破溃。头部、面部、颈部、肩部、胸部及背部可见数十个粟粒至黄豆大泛发性鲜红色丘疹,压之不褪色,无破溃、糜烂及渗出。诊断:反应性毛细血管增生症。A case of reactive cutaneous capillary endothelial proliferation caused by Camrilizumab is reported.A 69-year-old male presented with multiple bright-red papules all over the body for more than 4 months.Physical examination showed a dark-red mass with pedicle about the size of 1.5 cm×2 cm on the right side of the face.No ulcer was seen.Therewere dozens of millet grains to soybean-sized bright red papules seen on the head,neck,shoulder,chest and back.The rashes did not fade under pressure.Ulceration,erosion or exudation was not seen.The diagnosis of reactive cutaneous capillary endothelial proliferation was made.

关 键 词：卡瑞利珠单抗 反应性皮肤毛细血管增生症 

分 类 号：R758.25[医药卫生—皮肤病学与性病学]